image
Healthcare - Biotechnology - NASDAQ - US
$ 35.54
3.49 %
$ 2.04 B
Market Cap
3.05
P/E
INCOME STATEMENT
36.5 M REVENUE
36.07%
-426 M OPERATING INCOME
-8.75%
674 M NET INCOME
291.35%
EFFICIENCY
Earnings Waterfall Agios Pharmaceuticals, Inc.
image
Revenue 36.5 M
Cost Of Revenue 4.16 M
Gross Profit 32.3 M
Operating Expenses 458 M
Operating Income -426 M
Other Expenses -1.1 B
Net Income 674 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 36.5 26.8 14.2 0 203.2 117.9 94.4 43.0 69.9 59.1 65.4 25.5 25.1 21.8
GROSS PROFIT
Cost Of Revenue 4.2 9.5 1.7 18.8 2.8 1.3 1.4 292.7 220.2 141.8 100.4 54.5 41.0 0
Gross Profit 32.3 17.3 12.5 (18.8) 200.4 116.6 93.0 (249.7) (150.3) (82.7) (35.0) (29.0) (15.9) 21.8
OPERATING INCOME
Operating Expenses 458.1 408.8 401.6 378.4 516.5 542.9 455.5 363.8 270.9 177.8 119.5 64.4 48.1 38.5
Selling, General and Administrative Expenses 156.8 119.9 121.7 121.4 149.1 132.0 114.1 71.1 50.7 36.0 19.1 9.9 7.1 7.2
Research and Development Expenses 301.3 288.9 279.9 257.0 367.5 410.9 341.3 292.7 220.2 141.8 100.4 54.5 41.0 31.3
Operating Income (425.7) (391.5) (389.0) (378.4) (316.1) (426.3) (362.5) (320.8) (201.0) (118.7) (54.1) (38.9) (23.0) (16.6)
PRE-TAX INCOME
Interest Income Expense 0 0 12.8 0 17.8 0 16.5 6.1 2.5 1.0 0.2 55 K 69 K 0.1
Total Other Income 1 143.7 39.4 157.2 21.9 6.6 14.9 16.5 6.1 2.5 1.0 0.2 55 K 69 K 0.1
Pre-Tax Income 718.0 (352.1) (231.8) (356.5) (327.4) (411.5) (346.0) (314.7) (198.5) (117.7) (53.9) (38.8) (22.9) (16.5)
NET INCOME
Tax Provision 44.2 0 (157.2) (1 977.9) 7.8 (14.9) 32.9 (6.4) (5.7) (0.4) (0.4) 0.6 (2.8) 7.2
Net Income 673.7 (352.1) (74.6) 1 604.7 (335.2) (396.6) (346.0) (314.7) (198.5) (117.7) (53.5) (39.4) (20.1) (23.7)
EPS 11.9 6.33 1.36 26.6 4.86 6.61 6.03 6.75 5.07 3.15 1.59 2.56 0.86 1.01